Navigation Links
New Jersey Health Foundation Initiates Program To Spur Innovative Research
Date:9/10/2012

NEW BRUNSWICK, N.J., Sept. 10, 2012 /PRNewswire-USNewswire/ -- To help advance research in the scientific process, New Jersey Health Foundation is proud to announce the establishment of the New Jersey Health Innovation Stage Funding Program.

Through the new program, $500,000 has been allocated to provide funding in amounts starting at $10,000 up to a maximum of $50,000 each to researchers with promising ideas that may lead to developing patents or intellectual property.  At the current time, researchers with these objectives affiliated with the University of Medicine and Dentistry of New Jersey (UMDNJ) are able to apply for funding.

"New Jersey Health Foundation currently uses its own board-designated assets to support two programs to fund faculty affiliated with UMDNJ," explained Dean Janeway, chairman of the New Jersey Health Foundation Board. "This new program now allows us to fund research that needs investment toward commercialization in all stages—at the very beginning, in the middle stage and toward the end."

Research funding through New Jersey Health starts with the New Jersey Health Annual Grants Program, which has provided more than $50 million in grants to researchers and faculty members since inception of the program.  The grants, up to $40,000 each, provide seed and bridge funding for research projects and education programs. Typically, recipients are researchers who may not yet otherwise be eligible for traditional grant funding. 

"The $50 million that we have awarded through the Annual Grants Program is from our own board-designated funds, which is separate and in addition to money we have raised for research from donors," Mr. Janeway explained.

To support research at a further stage in the process, in 2006 New Jersey Health Foundation established Foundation Venture Capital Group with $5 million to provide investments in emerging medical research and technology being developed by new life science companies. These new companies are at a very early stage in research hoping to move toward commercialization.  The funding provided by FVCG is typically not available to these very early stage companies.  FVCG has invested in eight companies to date.

"During the process of reviewing potential researchers and licensed technology, it became evident that there was a gap in funding between the Annual Grants Program and FVCG investment," noted Dr. George F. Heinrich, vice chair and CEO of New Jersey Health Foundation. "An unmet funding need existed for researchers who are beyond the Annual Grants Program stage but not yet at FVCG investment stage."

For more information, contact Dr. Heinrich at (908) 731-6607 or heinrichmd@njhf.org or James M. Golubieski, president, at (908) 731-6601 or jgolubieski@njhf.org.

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org,) established in 2002 as a not-for-profit public charity, is the parent company to the Foundation of UMDNJ (www.foundationofumdnj.org) and The Foundation for Healthcare Advancement, which solicit private sector support for the University of Medicine and Dentistry of New Jersey and to Foundation Venture Capital Group, LLC,  (www.foundationventure.com) which makes private equity investments in start-up technology companies founded by researchers affiliated with the University.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
2. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
3. New Jersey Ophthamologist Now Offers Pelleve Wrinkle Reduction Treatment
4. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
5. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
6. H. D. Smith Names Timothy Booth Corporate VP, Home Healthcare (HHC), In First-of-its-Kind Leadership Appointment
7. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
8. Covance to Present at the Morgan Stanley Global Healthcare Conference
9. Amgen To Present At The Morgan Stanley Global Healthcare Conference
10. Feds Use Tougher Tactics To Fight Healthcare Fraud
11. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):